Long-term maintenance with P2Y12 inhibitor monotherapy after discontinuing dual antiplatelet therapy (DAPT) in patients ...

So-called transient ischemic attacks can eventually lead to cognitive declines as steep as those following a full-on stroke, new research finds. By Paula Span Kristin Kramer woke up early on a ...

versus intravenous thrombolysis (IVT) plus EVT on functional independence (modified Rankin Scale (mRS) 0–2) after acute ischemic stroke due to large vessel occlusions (AIS-LVO). Methods We searched ...

Objective To describe the benefits and risks of DAPT versus SAPT in patients with nonminor ... was no difference between DAPT and SAPT regarding recurrent stroke, ischemic stroke, hemorrhagic stroke, ...

Methods Data were extracted from the Endovascular Treatment in Ischemic Stroke (ETIS) registry ... Secondary outcomes included intracranial recanalization, hemorrhagic transformation and carotid stent ...

Background and purpose: The associations of lipid profiles with the risk of ischemic stroke (IS) or hemorrhagic stroke (HS ... were used to compare lipid profiles versus minimal lipid profiles ...

In this post hoc analysis of the ELAN trial (Early Versus Late Initiation of Direct Oral ... late initiation of direct oral anticoagulants in people with ischemic stroke with and without hemorrhagic ...

Objectives: To evaluate the difference between low-molecular-weight heparin (LMWH) and aspirin in preventing early neurological deterioration (END) and recurrent ischemic stroke (RIS), post ...

The primary end point was hemorrhagic stroke, and the secondary end points were ischemic stroke, stroke of any type ... 95% CI, 1.04–34.99) versus the lowest quartile, which was evident at higher mean ...

The primary efficacy outcome of THALES included hemorrhagic stroke ... fatal bleeding and fatal ischemic stroke was excluded. The greater risk of hemorrhage in the ticagrelor-aspirin group was driven ...

transient ischemic attack, hemorrhagic stroke). Inclusion criteria were RCTs of statins versus no therapy, high dose versus low dose statin therapy, PCSK9i versus no therapy, high dose versus low dose ...